Sermorelin Research for Cognitive Function
An evidence-based overview of research examining Sermorelin in the context of cognitive function. This page synthesizes findings from peer-reviewed literature.
Research Summary
A 20-week randomized controlled trial demonstrated that sermorelin treatment increased brain GABA levels in all measured regions and improved performance on tests of fluid intelligence including working memory, planning, selective attention, and processing speed.
The study included both healthy older adults and those with mild cognitive impairment (MCI), suggesting potential benefits across the cognitive aging spectrum. The GABA increase may mediate improved cognitive function through enhanced inhibitory neurotransmission.
Additional trials in healthy older adults showed GHRH improved cognitive function alongside sleep quality, supporting a role for optimized GH secretion in maintaining cognitive health during aging.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Cognitive Function
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Sermorelin may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.